UCI-1 – COVID-19 Peptides

University of California, Irvine Coronavirus Inhibitor-1 (UCI1-) is a cyclic peptide inhibitor that mimics the conformation of an Mpro substrate and binds at the C-terminal autolytic cleavage site of Mpro. UCI-1 is able to inhibit Mpro in vitro and is non-toxic to human cells in culture. The main protease (Mpro or 3CL protease) is a member of a class of homologous cysteine proteases that are needed for viral replication in coronavirus caused diseases such as severe acute respiratory syndrome (SARS)-CoV and SARS CoV-2 and Middle East respiratory syndrome (MERS) and therefore represents a key drug target for coronaviruses. UCI-1 contains amino acid side chains from the P2, P1, P1′, and P2′ positions of the Mpro substrate that are designed to fill the S2, S1, S1′, and S2′ pockets of the Mpro active site. UCI-1 acts as an inhibitor against Mpro, and lays the groundwork for developing further cyclic peptide inhibitor analogues of UCI-1.

Technical specification

Price